New Episode: The State of Psychedelics (Part 2) In this week’s special episode, Matias Serebrinsky chats with Dr. Rachel Yehuda and Zachary Haigney at Soho House in New York City. This is part 2 of a moderated panel recorded in front of a live audience, with part 1 released in June 2022. Listen here: https://lnkd.in/gRSrn_8Z Dr. Yehuda has spent the last 30 years doing research on PTSD and trauma and is leading the MDMA-assisted therapy research at the US Veterans Affairs Medical Center and serves as Director at the Mental Health at the JAMES J. PETER'S VA MEDICAL CENTER. She is also the Director of the Center for Psychedelic Psychotherapy and Trauma Research at the Icahn School of Medicine at Mount Sinai and Professor of Psychiatry and Neuroscience. Zach Haigney writes the The Trip Report by Beckley Waves, a newsletter about the science, policy, and business of psychedelics. In this episode, we discuss: - The potential of MDMA vs. psilocybin-assisted therapy for PTSD - The hype vs. the science of current psychedelic clinical trials - Psychedelic legislation approvals in Oregon and Colorado - The importance of harm reduction measures to prevent adverse events Thanks Liz Friedland for producing and organizing this event!
